Authorities allege that more than 100,000 investors were defrauded of ₹1,000 crore by being lured with promises of weekly ...
The US FDA has granted breakthrough therapy designation to Bluejay Therapeutics’ brelovitug, to treat chronic hepatitis delta ...
Junshi Biosciences and TopAlliance are set to enter a collaboration with LEO Pharma to distribute and market toripalimab in ...